Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Connective and Soft Tissue Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02651246
What this trial is testing

Optional Sub-study to Intraoperative Imaging With ICG Registry

Who this might be right for
Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) CancerCancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma CancerCancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer
Abramson Cancer Center at Penn Medicine 291
Testing effectiveness (Phase 2)Ended earlyNCT00686842
What this trial is testing

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Who this might be right for
Kaposi's Sarcoma
AIDS Malignancy Consortium 17
Not applicableStudy completedNCT02270086
What this trial is testing

Evaluating Bacterial Response in Sarcoma Management Using Fluorescence Imaging

Who this might be right for
Soft Tissue SarcomaWounds
University Health Network, Toronto 20
Testing effectiveness (Phase 2)UnknownNCT05189483
What this trial is testing

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma
Henan Cancer Hospital 40
Not applicableLooking for participantsNCT07298083
What this trial is testing

DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins

Who this might be right for
NeurofibromasMPNST
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Not applicableStudy completedNCT01334996
What this trial is testing

Use of Tamoxifen in Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
Mayo Clinic 1
Early research (Phase 1)Looking for participantsNCT06132503
What this trial is testing

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Who this might be right for
Relapsed or Refractory LymphomasAdvanced Solid Tumor
Lantern Pharma Inc. 110
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Not applicableActive Not RecruitingNCT05427461
What this trial is testing

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2

Who this might be right for
Leiomyosarcoma
Institut Claudius Regaud 20
Not applicableUnknownNCT06076070
What this trial is testing

GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers

Who this might be right for
Sarcoma
Regina Elena Cancer Institute 10
Not applicableEnded earlyNCT01271959
What this trial is testing

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Who this might be right for
Solid Organ Tumors
Precision Therapeutics 167
Testing effectiveness (Phase 2)WithdrawnNCT00978146
What this trial is testing

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Who this might be right for
Desmoid TumorsFibromatosis
Children's Hospital of Philadelphia
Not applicableStudy completedNCT00410488
What this trial is testing

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

Who this might be right for
SarcomaNauseaVomiting
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT00038142
What this trial is testing

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Who this might be right for
Ewing's Sarcoma
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Early research (Phase 1)Looking for participantsNCT07297979
What this trial is testing

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Who this might be right for
Ewing Sarcoma
Amgen 50
Large-scale testing (Phase 3)Study completedNCT00002546
What this trial is testing

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group 216
Post-approval studies (Phase 4)Study completedNCT02293447
What this trial is testing

Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization

Who this might be right for
Uterine Leiomyomas
University Health Network, Toronto 60
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Next Page